Zip Bio
Compressing Biology to Develop the Next Generation of Therapies
StartupZip Bio is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2023. Compressing Biology to Develop the Next Generation of Therapies. The company has raised a total of $4M across 1 funding round, currently at the Seed stage. Zip Bio was founded by Roee Farber and Ori Zelichov. Key investors include NFX Capital, MoreVC. The company has 1-10 employees.
With $4M in total funding, Zip Bio is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQTel Aviv-Yafo
- Last Round$4M
- NFX CapitalLead
- MoreVC
Roee FarberCo-founder & CEO
Ori ZelichovCo-founder, President & Chief Medical Officer
1 article covered by sources including www.geekwire.com.
What does Zip Bio do?
ZipBio utilizes generative artificial Intelligence to revolutionize the development of new therapeutics, addressing some of the most pressing unmet needs in medicine. By creating de novo genes and proteins, the company's solution distill multiple complex functions into compact, highly effective therapeutic molecules.
How much funding has Zip Bio raised?
Zip Bio has raised $4M in total funding across 1 rounds. The company is currently at the Seed stage. Key investors include NFX Capital, MoreVC.
Who founded Zip Bio?
Zip Bio was founded in 2023 by Roee Farber (Co-founder & CEO), Ori Zelichov (Co-founder, President & Chief Medical Officer).
What sector is Zip Bio in?
Zip Bio operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Zip Bio located?
Zip Bio is based in Tel Aviv-Yafo, Israel. The company also has offices abroad.